Their binding to the T cell co-inhibitory CD28 family receptors, including programmed cell death receptor 1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), results in decreased immune cell activity, allowing cancer cells to escape from immune surveillance [17]. The gene discussed is CD28; the disease is cancer.